Yenkel Bleyer-Grinberg
Lyon, 69008, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
The NF-κB RelA transcription factor is not required for CD8+ T-cell function in acute viral infection and cancer.
Journal: Frontiers in immunology
Published: January 31, 2024
A pan-cancer analysis implicates human NKIRAS1 as a tumor-suppressor gene.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 06, 2023
MDR1-EXPRESSING CD4+ T CELLS WITH TH1.17 FEATURES RESIST TO NEOADJUVANT CHEMOTHERAPY AND ARE ASSOCIATED WITH BREAST CANCER CLINICAL RESPONSE.
Journal: Journal for immunotherapy of cancer
Published: October 20, 2023
Deep phenotyping of nodal T-cell lymphomas reveals immune alterations and therapeutic targets.
Journal: Haematologica
Published: October 16, 2023
Xevinapant Combined with Pembrolizumab in Patients with Advanced, Pretreated, Colorectal and Pancreatic Cancer: Results of the Phase Ib/II CATRIPCA Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 09, 2023
NF-κB subunits RelA and c-Rel selectively control CD4+ T cell function in multiple sclerosis and cancer.
Journal: The Journal of experimental medicine
Published: August 01, 2023
Inhibition of anti-tumor immunity by NF-κB: Toward therapeutic targeting?
Journal: Medecine sciences : M/S
Published: February 18, 2022
ZEB1 transcription factor promotes immune escape in melanoma.
Journal: Journal for immunotherapy of cancer
Published: January 31, 2022
A T cell-intrinsic function for NF-κB RelB in experimental autoimmune encephalomyelitis.
Journal: Scientific reports
Published: August 10, 2021
The many-sided contributions of NF-κB to T-cell biology in health and disease.
Journal: International review of cell and molecular biology
Published: June 02, 2021
Last Updated: 09/26/2026